Case File №
#VI-2026-0350
Peptide Ark
Request Full Data Access to the VendorInvestigate database of peptide tests.
Exhibit I
Compounds on File
31 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| GHK-Cu | X Unrated | 1 | 4.9 | 4.9 | 4.9 | 24 May 2026 |
| Tesamorelin | X Unrated | 1 | 4.2 | 4.2 | 4.2 | 24 May 2026 |
| AA Water | X N/A | 1 | 4.0 | 1.1 | 1.1 | 3 Jun 2025 |
| Anadrol (Oxymetholone) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 7 May 2025 |
| Andarine S4 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 11 Jun 2025 |
| ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Jun 2025 |
| APAA (alpha-phenylacetoacetamide) CAS 102-01-2 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Apr 2025 |
| Blend 300 (TRA/Mast P/Test P) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| BPC-157 Capsule | X N/A | 1 | 4.0 | 1.9 | 1.9 | 8 Jul 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 4.0 | 1.9 | 1.9 | 2 Jul 2025 |
| Cardiogen | X N/A | 1 | 4.0 | 0.0 | 0.0 | 11 Jun 2025 |
| CJC-1295 With DAC | X N/A | 1 | 4.0 | 0.0 | 0.0 | 28 Mar 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 20 Jun 2025 |
| Crystagen | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jun 2025 |
| GW-501516 (Cardarine) | X N/A | 1 | 4.0 | 0.2 | 0.2 | 3 Jul 2025 |
| Humanin | X N/A | 1 | 4.0 | 1.9 | 1.9 | 20 Jun 2025 |
| Hyaluronic acid | X N/A | 1 | 4.0 | 2.6 | 2.6 | 21 May 2025 |
| Ivermectin | X N/A | 1 | 4.0 | 1.8 | 1.8 | 7 May 2025 |
| Lipo-B 216mg | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Jul 2025 |
| Livagen | X N/A | 1 | 4.0 | 0.0 | 0.0 | 11 Jun 2025 |
| Metribolone | X N/A | 1 | 4.0 | 1.4 | 1.4 | 25 Apr 2025 |
| MOTS-C | X N/A | 1 | 4.0 | 0.0 | 0.0 | 25 Apr 2025 |
| P21 | X N/A | 1 | 4.0 | 0.4 | 0.4 | 17 Dec 2024 |
| PEG MGF | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Apr 2025 |
| PNC 27 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 9 Jun 2025 |
| Superdrol Oil | X N/A | 1 | 4.0 | 1.6 | 1.6 | 14 Jan 2025 |
| Test Base (No Ester) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Jun 2025 |
| Test Enanthate | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Apr 2025 |
| Trenbolone Enanthate | X N/A | 1 | 4.0 | 1.5 | 1.5 | 20 Jun 2025 |
Exhibit II
Evidence Log
29 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | Hyaluronic acid | 4.0 C | 2mg | 2.3mg | +14.9% | 96.56% | gc4xt3 | Lab E | Public |
| 24 May 2026 | Retatrutide 5mg + Cagrilintide 5mg Blend | 4.0 C | 10mg | 9.7mg | -3.4% | 97.79% | kpe404 | Lab G | Community |
| 24 May 2026 | Andarine S4 | 4.0 C | 100mg | 92.3mg | -7.7% | 98.06% | 74sfva | Lab B | Public |
| 24 May 2026 | GW-501516 (Cardarine) | 4.1 C | 20mg | 19.2mg | -3.9% | 98.35% | p62erx | Lab D | Community |
| 24 May 2026 | CJC-1295 With DAC | 5.7 B | 2mg | 1.7mg | -12.8% | 98.52% | evtdjw | Lab A | Community |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.1 C | 10mg | 11.9mg | +18.6% | 99.12% | 4nnek7 | Lab F | Public |
| 24 May 2026 | Metribolone | 4.0 C | 200mg/ml | 191.5mg/ml | -4.2% | 99.13% | 45g0f1 | Lab E | Community |
| 24 May 2026 | Retatrutide 30mg Pen Kit | 4.0 C | 2mg | 2.1mg | +4.5% | 99.22% | zg3i3d | Lab C | Public |
| 23 May 2026 | BPC157 5mg + TB500 5mg Blend | 4.0 C | 5mg | 6.0mg | +20.8% | 97.17% | ytbnob | Lab F | Community |
| 23 May 2026 | Lipo-B 216mg | 5.4 B | 300mg/ml | 282.0mg/ml | -6.0% | 97.35% | 7upspt | Lab F | Public |
| 21 May 2026 | Superdrol Oil | 4.0 C | 250mg/ml | 249.5mg/ml | -0.2% | 97.70% | vz6ht6 | Lab E | Community |
| 21 May 2026 | Humanin | 5.5 B | 50mg | 48.3mg | -3.4% | 99.82% | jdk7nd | Lab G | Public |
| 20 May 2026 | PEG MGF | 4.0 C | 30mg | 26.6mg | -11.5% | 95.50% | 9szwpn | Lab A | Community |
| 19 May 2026 | PNC 27 | 6.0 A | 20mg | 18.5mg | -7.7% | 98.48% | 2moavz | Lab B | Public |
| 29 Jan 2026 | Cardiogen | 4.0 C | 50mg | 58.3mg | +16.6% | 97.07% | z4bvjw | Lab G | Public |
| 29 Jan 2026 | MOTS-C | 6.2 A | 50mg | 48.1mg | -3.9% | 98.39% | abs34l | Lab D | Public |
| 26 Jan 2026 | Test Base (No Ester) | 5.3 B | 250mg/ml | 256.9mg/ml | +2.8% | 96.08% | 1goflx | Lab G | Community |
| 7 Jan 2026 | Livagen | 4.0 C | 15mg | 13.8mg | -7.9% | 95.46% | nmxvgs | Lab D | Community |
| 29 Dec 2025 | Crystagen | 4.0 C | 5mg | 5.9mg | +17.0% | 96.74% | wypu4u | Lab D | Public |
| 12 Dec 2025 | Trenbolone Enanthate | 4.0 C | 250mg/ml | 287.3mg/ml | +14.9% | 97.75% | kvm93o | Lab D | Public |
| 5 Dec 2025 | ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | 5.1 B | 1g | 0.9g | -8.5% | 98.78% | b2tx77 | Lab E | Community |
| 23 Nov 2025 | P21 | 6.4 A | 20mg | 18.8mg | -6.1% | 96.46% | 8yrl9x | Lab F | Public |
| 23 Nov 2025 | Test Enanthate | 6.3 A | 100mg/ml | 115.7mg/ml | +15.7% | 98.63% | 1ftc9r | Lab C | Community |
| 17 Nov 2025 | AA Water | 4.0 C | 5mg | 4.5mg | -10.9% | 96.79% | q8gpl0 | Lab B | Public |
| 17 Nov 2025 | Ivermectin | 4.7 C | 20mg | 18.0mg | -9.9% | 96.07% | 50s1im | Lab E | Public |
| 5 Nov 2025 | Blend 300 (TRA/Mast P/Test P) | 4.1 C | 200mg/ml | 177.1mg/ml | -11.5% | 96.97% | t6fvuf | Lab C | Community |
| 4 Nov 2025 | Anadrol (Oxymetholone) | 4.6 C | 20mg | 21.3mg | +6.3% | 98.88% | qz9z5l | Lab E | Community |
| 4 Nov 2025 | BPC-157 Capsule | 4.1 C | 20mg | 20.6mg | +2.9% | 96.33% | ts51do | Lab F | Community |
| 17 Oct 2025 | APAA (alpha-phenylacetoacetamide) CAS 102-01-2 | 4.0 C | 10g | 8.8g | -12.3% | 98.16% | tczn2a | Lab G | Public |